Literature DB >> 9315522

Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women.

T T Nguyen1, R D Ellefson, D O Hodge, K R Bailey, T E Kottke, H S Abu-Lebdeh.   

Abstract

BACKGROUND: Elevated lipoprotein(a) [Lp(a)] levels have been associated with the presence of atherosclerotic disease. However, the results of prospective studies of Lp(a) and cardiovascular disease have been contradictory. METHODS AND
RESULTS: From 1968 through 1982, lipoprotein analysis was performed in 11,335 Olmsted County residents. Quantitative cholesterol and triglycerides were obtained along with semiquantitative Lp(a) levels based on electrophoretic pattern. Lp(a) bands were scored from 0 (absent) to 3 (increased). A cohort of 4967 men and 4968 women with no prior history of atherosclerotic disease who had baseline Lp(a) determinations were followed up for 14 years for development of coronary artery disease (CAD) and cerebrovascular disease (CVD). During 131,330 person-years of follow-up, there were 1848 CAD events and 841 CVD events. Age, diabetes, hypertension, cholesterol, and triglycerides were significantly and independently associated with an increased risk of CAD and CVD in men and women. There was a significant increase in the adjusted hazards ratio for CAD with increasing Lp(a) levels for men and women. For Lp(a) level 3, the hazard ratio was 1.9 (range, 1.3 to 2.9) in women and 1.6 (range, 1.0 to 2.5) in men. The adjusted hazard ratio for CVD showed an irregular association with Lp(a) levels in men and no association in women.
CONCLUSIONS: In this cohort of 9936 men and women initially free of cardiovascular disease who were followed up for 14 years, Lp(a) was a significant predictor of risk of future CAD. Lp(a) was a weak risk factor for CVD in men and was not a significant predictor of CVD risk in women.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315522     DOI: 10.1161/01.cir.96.5.1390

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

Review 1.  [Angiology update].

Authors:  C Ranke; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-05-15

Review 2.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

Review 3.  Novel serologic markers of cardiovascular risk.

Authors:  Guilherme H M Oliveira
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

4.  Serum Lipids and Lipoproteins During Uncomplicated Malaria: A Cohort Study in Lambaréné, Gabon.

Authors:  Benjamin J Visser; Sophia G de Vries; Rieke Vingerling; Martin Gritter; Danielle Kroon; Lídia Ciudad Aguilar; Rik B J Kraan; Rosanne W Wieten; François Danion; Barbara Sjouke; Akim A Adegnika; Selidji T Agnandji; Peter G Kremsner; Thomas Hänscheid; Petra F Mens; Michèle van Vugt; Martin P Grobusch
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

Review 5.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

6.  Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistance.

Authors:  Alice Liu; James Cardell; Danit Ariel; Cindy Lamendola; Fahim Abbasi; Sun H Kim; Tyson H Holmes; Vanessa Tomasso; Hafasa Mojaddidi; Kaylene Grove; Clete A Kushida; Gerald M Reaven
Journal:  Sleep       Date:  2015-05-01       Impact factor: 5.849

Review 7.  Hormone replacement therapy in the prevention and treatment of atherosclerosis.

Authors:  L Mosca
Journal:  Curr Atheroscler Rep       Date:  2000-07       Impact factor: 5.113

8.  Increased stroke risk and lipoprotein(a) in a multiethnic community: the Northern Manhattan Stroke Study.

Authors:  Bernadette Boden-Albala; Douglas E Kargman; I-Feng Lin; Myunghee C Paik; Ralph L Sacco; Lars Berglund
Journal:  Cerebrovasc Dis       Date:  2010-07-23       Impact factor: 2.762

Review 9.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Authors:  Sebhat Erqou; Stephen Kaptoge; Philip L Perry; Emanuele Di Angelantonio; Alexander Thompson; Ian R White; Santica M Marcovina; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-07-22       Impact factor: 56.272

Review 10.  Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions.

Authors:  Ozlem Bilen; Ayeesha Kamal; Salim S Virani
Journal:  World J Cardiol       Date:  2016-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.